Propensity score analysis with partially observed confounders: how
  should multiple imputation be used? by Leyrat, Clemence et al.
Propensity score analysis with partially observed
confounders: how should multiple imputation be
used?
Cle´mence Leyrat 1, Shaun R. Seaman 2, Ian R. White 2,
Ian Douglas 3, Liam Smeeth 3, Joseph Kim 1,4,
Matthieu Resche-Rigon 5,6, James R. Carpenter 1,7 and Elizabeth J. Williamson1,8
October 2, 2016
1Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London
WC1E 7HT, UK
2MRC Biostatistics Unit, Cambridge CB2 0SR, UK
3Department of Epidemiology and Population Health, London School of Hygiene and Tropical
Medicine, London WC1E 7HT, UK
4IMS Health, Real-World Evidence Solutions, London N1 9JY , UK
5SBIM Biostatistics and Medical information, Hpital Saint-Louis, APHP, 75010 Paris, France
6ECSTRA Team (Epidmiologie Clinique et Statistiques pour la Recherche en Sant), UMR
1153 INSERM, Universit Paris Diderot, Sorbonne Paris Cit, 75010 Paris, France
7MRC Clinical Trials Unit at UCL, London WC2B 6NH, UK
8Farr Institute of Health Informatics, London NW1 2DA, UK
Corresponding author: Cle´mence Leyrat, London School of Hygiene and Tropical Medicine.
Department of Medical Statistics. Keppel Street, London WC1E 7HT. UK
clemence.leyrat@lshtm.ac.uk
Abstract
Inverse probability of treatment weighting (IPTW) is a popular propen-
sity score (PS)-based approach to estimate causal effects in observational
studies at risk of confounding bias. A major issue when estimating the
PS is the presence of partially observed covariates. Multiple imputation
(MI) is a natural approach to handle missing data on covariates, but its
use in the PS context raises three important questions: (i) should we ap-
ply Rubin’s rules to the IPTW treatment effect estimates or to the PS
estimates themselves? (ii) does the outcome have to be included in the
imputation model? (iii) how should we estimate the variance of the IPTW
estimator after MI? We performed a simulation study focusing on the ef-
fect of a binary treatment on a binary outcome with three confounders
(two of them partially observed). We used MI with chained equations
to create complete datasets and compared three ways of combining the
results: combining treatment effect estimates (MIte); combining the PS
across the imputed datasets (MIps); or combining the PS parameters and
estimating the PS of the average covariates across the imputed datasets
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(MIpar). We also compared the performance of these methods to complete
case (CC) analysis and the missingness pattern (MP) approach, a method
which uses a different PS model for each pattern of missingness. We also
studied empirically the consistency of these 3 MI estimators. Under a
missing at random (MAR) mechanism, CC and MP analyses were biased
in most cases when estimating the marginal treatment effect, whereas MI
approaches had good performance in reducing bias as long as the outcome
was included in the imputation model. However, only MIte was unbiased
in all the studied scenarios and Rubin’s rules provided good variance es-
timates for MIte. In practice, the PS estimated in the MIte approach
showed good balancing properties, whereas the estimated PS in MIps and
MIpar only balanced the observed part of the confounders. Nevertheless,
in some situations, MIpar removed a large part of the confounding bias in
the treatment effect estimate. We propose a variance estimator for MIpar,
which has good statistical properties in our simulations. In conclusion,
when using MI in the IPTW context, MIte with the outcome included in
the imputation model is the preferred approach.
Keywords: propensity score, missing confounders, multiple imputation, chained
equations, Rubin’s rules, inverse probability of treatment weighting, missingness
pattern
1 Introduction
Data from observational studies provide useful information to address health-
related questions and notably estimate treatment effect in real settings [1]. How-
ever, because individuals are not randomised, the study groups are often not
comparable, which may lead to confounding bias [2] if these studies are ana-
lyzed without appropriate adjustment for confounding. Propensity scores (PS)
have been proposed as a means to recover balance between groups on observed
confounders and so obtain a consistent estimate of the causal treatment effect
[3]. The PS is defined as the individual’s probability of receiving the treatment
rather than the control given their baseline characteristics [4]. One popular
method to achieve covariate balance between treatment groups is to re-weight
individuals according to their PS value. This approach, known as inverse proba-
bility of treatment weighting (IPTW) [5] aims to emulate the sample that would
have been observed in a randomised trial. In practice, a major issue when es-
timating the PS is the presence of partially observed confounders, as the PS
cannot be estimated for individuals with at least one missing covariate value.
A simple solution is to perform the analysis using only data those individuals
with complete records (i.e. with complete baseline measurements), but such an
approach can lead to a biased estimate of the treatment effect if the missingness
mechanism is associated with the outcome [6]. Another approach, proposed by
Rosenbaum and Rubin [7], is to use missingness patterns (MP) to estimate a
generalised propensity score: individuals are classified according their pattern
of missingness, and then the PS is estimated within each pattern using the fully
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observed confounders for these individuals. This approach has three drawbacks:
it relies on strong assumptions, some confounders are ignored for some patterns
and it needs to have a sample size large enough in each stratum to estimate
the PS [8]. A popular alternative to handle missing data is multiple imputation
(MI). MI is used to fill in missing confounders a given number of times, replacing
the missing values by random draws from the appropriate predictive distribu-
tion. The model parameters are estimated in the resulting imputed datasets and
then are combined using Rubin’s rules to obtain the overall parameter estimates
and their variance accounting for the presence of missing data [9]. Because the
IPTW estimator is a two-step estimator (involving models for PS estimation
and treatment effect estimation, respectively), Rubin’s rules could be applied in
several different ways. First, the IPTW estimator could be applied to each of
the imputed datasets and then the resulting estimates averaged (MIte). Second,
each individual’s PS could be averaged over the imputed datasets and then these
PSs used to calculate a single IPTW estimate (MIps). Third, the PS parameters
and each individual’s imputed confounders could be averaged over the imputed
datasets and these used to calculate a single IPTW estimate (MIpar). MI of
partially observed confounders in the PS model has been used in applications
[10, 11], and studied through simulations for PS matching [12, 13]. However,
unresolved questions remain about how to use MI in the context of IPTW. In
particular, it is still unclear if combining the treatment effects across the im-
puted datasets outperforms the methods of combining the PSs, as well as if the
outcome must be included in the imputation model.
Moreover, little is known about the variance of the IPTW estimator when
combining the PS parameters. Thus, the aim of this work is to study the three
different MI strategies described above to handle missing confounders for IPTW,
and to compare them with CC analysis and the MP approach.
This paper is organised as follows: we first present a motivating example
looking at the effect of statins on short-term mortality after pneumonia in Sec-
tion 2. A brief description of IPTW in complete data, its variance and its under-
lying assumptions is given in Section 3. Section 4 presents different strategies to
handle partially missing confounders for PS analysis, focusing in particular on
MI. We provide an approximately unbiased estimator of the variance for IPTW
when combining the PS parameters. The consistency and balancing properties
of the MI approaches are studied in Section 5. Section 6 and 7 present the
methods and results of a simulation study assessing the performance of these
methods to estimate treatment effect with IPTW for binary outcomes. The
application of these approaches to the statin motivating example is presented
in Section 8, followed by a discussion in Section 9.
3
2 Motivating example: effect of statin use on
short-term mortality after pneumonia
To illustrate the importance of an adequate handling of missing confounders for
PS analysis, we focused on a published study of the effect of statin use on short
term mortality after pneumonia [14]. We utilised the THIN database, which
consists of anonymised patient records from general practitioners (GPs) in the
UK. As of the end of 2015, the database represented 3.5 million unique active
patients, or approximately 6% of the UK population. The database has been
found to be broadly representative of the UK population, and the validity of
recorded information has been established in previous studies [15, 16]. Douglas
et al carried out an analysis of 9073 patients who had a pneumonia episode, of
whom 1398 were under statin treatment when pneumonia was diagnosed. In the
statin group, 305 patients (21.8%) died within 6 months, while 2839 (37.0%)
of the non-users died within 6 months. However, statin users and non users
were very different in terms of characteristics, in particular on characteristics
associated with mortality.
In Douglas et al, propensity scores were used to recover balance between
groups. However, three important potential confounders were only partially ob-
served: body mass index (BMI), smoking status and alcohol consumption, with
respectively 19.2%, 6.2% and 18.5% of missing data. In the original analysis, a
missing indicator method was used. This approach is similar to the missingness
pattern approach described later in this paper.
3 Inverse probability of treatment weighting
3.1 Propensity score estimation and assumptions
Propensity scores (PS) were first introduced by Rosenbaum and Rubin in the
context of observational studies with confounding [3]. The PS has become a
major tool in causal inference to estimate the causal effect of a binary treat-
ment Z (Z = 1 if treated, Z = 0 otherwise). Formally, PS is the individual’s
probability of receiving the treatment conditional on the individual’s charac-
teristics. The PS is usually estimated from the data using a logistic regression
model which predicts each individual’s probability of receiving the treatment
from their baseline characteristics [17]:
eˆi =
exp(xTi αˆ)
1 + exp(xTi αˆ)
, (1)
where eˆi is the estimated PS for individual i (i = 1, ..., n), xi = (1, ..., Xpi) the
vector of p observed baseline confounders and the intercept for individual i and
αˆ is the (p+1) vector of maximum likelihood estimates for the PS parameters.
The PS approach can be viewed within the Neyman-Rubin counterfactual
framework for causal inference [18]. In this framework, the causal effect of the
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treatment is defined as the contrast of the two potential outcomes (counterfac-
tuals) Y Z=0 and Y Z=1, which are the outcomes that would have been observed
if an individual had been not treated and treated, respectively. Three assump-
tions are needed to consistently estimate the causal effect of a treatment, and
thus needed for PS analysis:
1. Positivity assumption: each individual has a non-null probability of re-
ceiving either treatment [19]
2. Stable unit treatment value assumption (SUTVA): each individual has
only one possible potential outcome value for each treatment [20]. This
assumption can be divided in two parts [21]:
• each of the two potential outcomes is always the same for a given
individual, whatever the conditions in which the treatment has been
received, i.e. Y = Y z if Z = z, where Y is the observed outcome.
In other words, the treatment has the same effect on the individual’s
outcome regardless of how the individual came to be treated. This
assumption is also called consistency
• the two potential outcome values for an individual are not affected
by the treatment received by other individuals
3. Strongly ignorable treatment assignment (SITA): treatment allocation
and the potential outcomes are conditionally independent given the con-
founders, i.e. (Y Z=0, Y Z=1) ⊥ Z|x. This implies that there are no un-
measured confounders.
The key property of the PS is that it is a balancing score. That is, if these
assumptions are valid and the PS model is correctly specified (the functional
form of the PS is correct), the variables included in the PS model are balanced
between treatment groups at any level of the PS. In other words, individuals with
close PS values have similar distribution of their characteristics. This balancing
property of the PS and the three assumptions lead to the consistency of PS-based
estimators. Initially, Rosenbaum and Rubin proposed three different PS-based
approaches to estimate causal effects [3]: PS matching, subclassification (also
known as stratification) and covariate adjustment. Although PS matching is the
most common approach used nowadays, two major limitations exist: matching
often discards a substantial number of individual from the analysis [22] and
variance estimation after PS matching is not straightforward [23]. The two other
approaches have drawbacks as well: residual bias due to heterogeneity within
strata can remain with subclassification [7], whereas covariate adjustment can be
biased in some circumstances [24]. In addition, covariate adjustment provides a
conditional, rather than a marginal effect. Thus, we focus on a fourth PS-based
approach [25]: inverse probability of treatment weighting (IPTW).
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3.2 IPTW estimator and its variance for complete data
IPTW aims to create a pseudo-population similar to a randomised trial by re-
weighting the individuals according to the inverse of their probability of receiving
the treatment they actually received (i.e. eˆ−1i for treated individuals and (1 −
eˆi)
−1 for untreated individuals). Thus, the IPTW estimators for the marginal
proportions for a binary outcome Y , µ1 and µ0, among the treated and the
untreated are [26]:
µˆ1 =
(
n∑
i=1
YiZi
eˆi
)(
n∑
i=1
Zi
eˆi
)−1
, µˆ0 =
(
n∑
i=1
Yi(1− Zi)
1− eˆi
)(
n∑
i=1
1− Zi
1− eˆi
)−1
.
(2)
Zi is the treatment indicator for individual i (Zi = 1 if treated, 0 otherwise)
and Yi is their outcome value. From these two marginal estimates, it is possible
to estimate a relative risk
(
µˆ1
µˆ0
)
, an odds ratio
(
µˆ1/(1−µˆ1)
µˆ0/(1−µˆ0)
)
or a risk difference
(µˆ1 − µˆ0) for a binary outcome.
The IPTW estimator, as with other PS-based estimators, is a ”two-step es-
timator”: a first step is needed for the PS estimation and the second step is
the treatment effect estimation. If the uncertainty linked to the PS estimation
in the first step is not taken into account in a second step, the repeated sam-
pling variance of the treatment effect will be overestimated and inference will
be conservative [23]. Lunceford and Davidian [27] and Williamson et al. [26]
proposed a large-sample variance estimator for the IPTW treatment effect es-
timator in which a correction term including the variance/covariance matrix of
the estimated PS parameters is applied.
4 Handling missing data in propensity score anal-
ysis
A major issue in PS estimation from model (6) is the presence of partially
observed confounders, which can lead to bias in the treatment effect estimate
if ignored. In this section, we describe five methods for applying IPTW on
incomplete data. We assume the treatment status Z and outcome Y are fully
observed.
4.1 Complete case analysis
Complete case analysis (or complete records analysis) is the most basic method
in the presence of missing data. The PS is estimated only within the subgroup of
individuals with observed values for all of the variables included in the PS model,
and only these individuals contribute to the estimation of the treatment effect
[13]. Although the complete case analysis provides an unbiased estimate of the
parameters of an outcome regression model when the missingness is independent
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of the outcome [6], little is known about complete case analysis for IPTW.
Moreover, excluding individuals with missing confounders can reduce statistical
power, particularly when the rate of missing data is high, because no use is
made of partially observed records.
4.2 Missingness pattern approach
The missingness pattern approach for PS analysis was first introduced by Rosen-
baum and Rubin [7]. They defined a generalized PS eˆ∗ as the probability of
receiving the treatment given the observed confounders and the pattern of miss-
ing data. In practice, the PS is estimated separately in each stratum defined by
missingness patterns. For example, if two variables X and W are partially ob-
served, 4 different missingness patterns can exist: X and W are both observed,
X is observed but W is missing, X is missing and W is observed, or X and W are
both missing. In each stratum, the PS is estimated from the confounders ob-
served in that stratum. Under an extension of the SITA assumption, i.e. when
treatment allocation is independent of the potential outcomes given the ob-
served confounders and the missingness pattern, i.e. (Y Z=0, Y Z=1) ⊥ Z|xobs, r
where xobs is the observed component of X and r is the missingness pattern, the
generalized propensity score balances the observed component of the partially
observed confounders and the missingness indicators. However, this generalized
PS does not balance the unobserved component of the variables [28].
4.3 Multiple imputation
4.3.1 Principles
Multiple imputation (MI) is a popular approach to handle missing data
because of its flexibility and its efficiency in a large variety of contexts and its
implementation in many statistical software packages. The principle of MI is to
generate a set of plausible values for the missing variables by drawing from the
posterior predictive distribution of these variables given the observed data. M
complete datasets are created and analysed independently to produce estimates
θˆk, (k = 1, ...,M) of θ the vector of the parameters of interest (eg. regression
coefficients) and estimatesW k of their associated variance matrix. Then θˆk and
W k , (k = 1, ...,M) are combined across the M imputed datasets. Following
Rubin’s rules, the overall estimate θˆMI of θ and estimate of the variance of
θˆMI , V̂ ar(θˆMI), are estimated as follows [9]:
θˆMI =
1
M
M∑
k=1
θˆk, V̂ ar(θˆMI) = W +
(
1 +
1
M
)
B, (3)
whereW is the within-imputation variance-covariance matrix, which reflects the
variability of the parameter estimates in each imputed dataset, and B is the
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between-imputation variance matrix reflecting the variability in the estimates
caused by the missing information. These two components are defined as:
W =
1
M
M∑
k=1
W k, B =
1
M − 1
M∑
k=1
(
θˆk − θˆMI
)2
. (4)
Two approaches exist to impute datasets: joint modelling and chained equa-
tions. Joint modelling consists of imputing missing values from a common para-
metric joint model for the complete data (often a multivariate normal model)
[29]. However, when variables are of different types, the existing classes of joint
models may not be appropriate. The second approach, chained equations (also
known as fully conditional specification) is more flexible in case of different
variable types since a specific imputation model is specified for each partially
observed variable [30]. Because of its flexibility, we focused on this approach in
the context of PS.
4.3.2 How to apply Rubin’s rules for PS analysis
Hayes and Groner used MI to estimate the PS from partially observed con-
founders in a study looking at the effect of seat belt usage on injury severity
[10]. However, instead of combining information from their 15 imputed datasets,
they randomly selected one complete record per individual and then estimated
the PS. Because this approach does not keep the entire benefit of MI, two ap-
proaches to combine information from the imputed datasets have been proposed
in the context of propensity score analyses: applying Rubin’s rules on the treat-
ment effect or applying Rubin’s rules on the PS itself. The former approach is
the natural MI approach in which the parameter which is combined is also the
parameter of interest: a PS model is fitted on each imputed dataset, and the
resulting PSs used to estimate a treatment effect. Then formula (3) is applied
to obtain an overall treatment effect and its variance [12, 13]. Seaman and
White [31] showed that Rubin’s rule for estimating the variance performs well
in practice in this setting, although theoretical justification for Rubin’s rules
relies on the parameter of interest being estimated with maximum likelihood,
which is not the case for the IPTW method. We will refer to this approach as
MIte hereafter. The second approach used in the literature consists of combin-
ing each individual’s PS across the imputed datasets (to obtain an average PS
for each individual) and then using these PSs to estimate a single treatment
effect estimate [12, 13]. This method is called MIps hereafter. Because the PS
is unlikely to follow a normal distribution, taking the average PS may not be
appropriate. Thus, we propose a third combination method for PS analysis af-
ter MI, in which the PS parameter estimates αˆ (ie.the regression coefficients of
the PS model) are combined rather than the PS itself. Then these parameters
are used to estimate the PS corresponding to an individual’s average imputed
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confounder values:
eˆi (x¯) =
expα¯x¯i
1 + expα¯x¯i
, (5)
(i = 1, ..., n) with α¯ the (p + 1) vector of the average PS parameter val-
ues (for the p confounders and the intercept) and x¯i a (p + 1) vector of the
average p confounders across imputed datasets for individual i. This method
will be referred to as MIpar. Whereas the MIps estimate of treatment effect
is based on the average PS, e¯i (xi), the MIpar estimate is based on the PS of
the average confounders, ei (x¯). The 3 MI approaches are illustrated in Figure 1.
Because the PS is obtained from M imputations, the standard variance
estimator for the IPTW treatment effect for MIps and MIpar is no longer valid
since it does not take into account the presence of missing data. A large-sample
estimate of the variance for MIpar, derived from [26], is detailed in Appendix 1.
The question of which PS strategy is preferable, as well as how to estimate
the variance for MIps is still unresolved. Moreover, the MIte and MIps methods
have mainly been studied for PS matching [12, 13], suggesting a better reduc-
tion of the bias observed in CC analysis with MIps than with MIte. Qu and
Lipkovitch [8] and Seaman and White [31] assessed the performance of MIte
additionally including the missingness pattern indicator in the PS model, but
they did not compare this approach to other combination rules after MI. For PS
stratification Crowe et al. [32] showed empirically that MIte has good statistical
properties. However, little is known about performance of MIte and MIps in
the context of IPTW.
To our knowledge, the only simulation study comparing MIte and MIps with
MI for IPTW did not take into account the outcome in the imputation model
[12], which could explain the bias observed in their study both for MIte and
MIps. When using the PS approach, the fitting of the PS regression model is a
first step to estimating the quantity which is of principal interest, namely the
treatment effect. An attraction of this approach is that it enables the choice
of how to adjust for confounding to be made without needing data on the out-
come: choosing and fitting the PS model requires data only on covariates and
treatment. This helps the user to avoid the temptation to search for a PS model
that gives a significant treatment effect estimate. Intuition may therefore lead
one to believe that imputation of missing covariates should also be done without
using the outcome variable [12]. However, this intuition conflicts with advice
to include the outcome when imputing missing covariates in a regression model
whose parameters are the quantities of interest [33]. In this setting, excluding
the outcome causes the parameter estimates to be biased towards the null. The
question remains, therefore, whether or not the outcome should be included
when imputing missing covariates in the PS model.
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5 Balancing properties and consistency of IPTW
estimator after MI
Without missing data, Rosenbaum and Rubin showed that the PS is a balancing
score [3]. A balancing score b(x) is defined as a function of the observed con-
founders x such that the conditional distribution of x given b(x) is the same for
Z = 0 and Z = 1. Moreover, Rosenbaum and Rubin showed that any balancing
score b(x) is ’finer’ than the true PS, that is e(x) = f {b(x)}, for some function
f(.). The consistency of PS estimators comes from this balancing property.
Lunceford and Davidian [27] studied theoretical properties of the IPTW estima-
tor when data are complete including a proof of consistency of this estimator.
In this section, we study the consistency of the IPTW estimators obtained from
MIte, MIps and MIpar and how this relates to balancing properties of the PS
models used in these approaches. We suppose hereafter that (i) the SITA as-
sumption required for IPTW (see 3.1) holds, (ii) the missing data are missing
at random (MAR) and (iii) the imputation model is correctly specified. For
simplicity, we consider here the estimation of θ = E[Y Z=1].
5.1 Combining the treatment effects after MI (MIte)
Let X, the vector of confounders, be split into fully observed and missing com-
ponents, X = (Xobs,Xmiss). X
(k)
m is the imputed value of Xmiss in the k
th
imputed dataset (k = 1, ..,M). We show (see Appendix 2a) that in each im-
puted dataset:
e(Xobs,X
(k)
m ) = E[Z|Xobs,X(k)m ]. (6)
If X
(k)
m is imputed from the true model (i.e. correctly specified at the true
parameter values), we can also show (Appendix 2b) that a SITA-type assump-
tion holds in each imputed dataset, i.e.:
Y Z=1 ⊥ Z |Xobs,X(k)m (7)
Y Z=0 ⊥ Z |Xobs,X(k)m
These two assumptions are the imputed-data version of what Imbens calls weak
unconfoundedness [34]. Note that we do not have the analogy of the usual,
stronger, assumption
(Y z=1, Y z=0) ⊥ Z |Xobs,X(k)m ,
which requires the treatment to be independent of the set of potential outcomes.
This is because our imputation model is a model for Xmiss|Z = z, Y Z=z,Xobs.
The stronger assumption would require our imputation model to capture Xmiss|Z =
z, Y Z=0, Y Z=1,Xobs. However, it is important to note, as Imbens does, that the
weak unconfoundedness suffices to obtain unbiased estimates of the causal treat-
ment effect.
10
Balancing properties: We have shown in Appendix 2 that
Xobs ⊥ Z | e(Xobs,X(k)m )
X(k)m ⊥ Z | e(Xobs,X(k)m ).
Thus the true PS in each completed dataset balance both the unobserved and
the imputed values of the confounders across treatment groups. This balancing
property is what leads to consistency of the MIte estimator. In practice, the PS
has to be estimated.
Consistency: Seaman and White [31] proved that for an infinite number
of imputations, the estimator obtained by combining the treatment effects after
MI (MIte) is consistent. To understand how this consistency relates to the
SITA-type assumption above, it is helpful to consider the following expectation:
E
[
Y Z
e(Xobs,X
(k)
m )
]
= E
[
E
[
Y Z
e(Xobs,X
(k)
m )
∣∣∣∣∣Xobs,X(k)m
]]
becauseZ = 0, 1
= E
[
E[Y Z=1|Xobs,X(k)m ] E[Z|Xobs,X(k)m ]
e(Xobs,X
(k)
m )
]
(8)
= E[E[Y Z=1|Xobs,X(k)m ]] (9)
= E[Y Z=1]
= θ,
Step 8 requires the SITA-type assumption 7. Step 9 relies on PS in the kth im-
puted dataset being equal to the probability of being treated given the observed
and imputed part of the confounders (equation 6).
5.2 Combining the PS or the PS parameters after MI
(MIps and MIpar)
For PS methods, consistency comes from the ability of PS to balance con-
founders between groups. MIps and MIpar create a single overall PS used
to estimate the treatment effect. Thus, consistency for these methods would
rely on the ability of these overall PS to balance both the observed and the
missing parts of the confounders. However, when combining the PS or the PS
parameters, the overall PS used for the analysis is not a function of the observed
confounders. Thus, the pooled PS (as estimated either in MIps or MIpar) is
not ’finer’ than the true PS according to Rosenbaum and Rubin’s definition [3]
(i.e. the true PS is not a function of the pooled PS). Consequently, it cannot
be a balancing score. Thus we do not have Xobs,Xmiss ⊥ Z|(e¯) (with e¯ the
relevant pooled PS). Therefore, neither θˆMIps nor θˆMIpar are consistent estima-
tors. We illustrate the lack of consistency with a counter example in Appendix
3. We also discuss the balancing properties of the MP approach in Appendix 4.
However, in practice, the consequences of this inconsistency on the treatment
effect estimate is not known. So we performed a simulation study to assess the
performance of these estimators under different scenarios.
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6 Simulation study
The aim of this simulation study is to assess the performance of the three MI
approaches, complete case analysis and missingness pattern approach for IPTW
when the outcome is binary.
6.1 Data generation
We generated datasets of sample size n = 2000, reflecting an observational study
comparing a treatment Z = 1 to a control treatment Z = 0 on a fully observed
binary outcome Y with 3 measured confounders X = (X1, X2, X3). X1 and X2
were continuous and X3 was binary. X2 was fully observed whereas X1 and X3
were partially observed. We generated the data as follows:
• Covariates: The 3 confounders X = (X1, X2, X3) are generated from a
multivariate normal distribution X ∼ N3(0,Σ), with Σii = 1 and Σij = ρ
for i 6= j. X3 is then dichotomised according to a threshold of 0 to obtain
a prevalence of 0.5. We considered two values for ρ : ρ = 0.3 and ρ = 0.6
corresponding to a moderate and strong correlation between confounders.
After dichotomization, corr(X1, X3) = corr(X2, X3) = 0.24 for ρ = 0.3
and 0.48 for ρ = 0.6.
• Treatment assignment depends on X according to the following model:
logit(p(Z = 1|x)) = −1.15 + 0.7x1 + 0.6x2 + 0.6x3. (10)
These coefficients give E(Z) = pZ = 0.3 and an important imbalance on
confounders between treatment groups, as shown in Figure 1 of the Ap-
pendices.
• Binary outcome: The outcome depends on the 3 confounders and the
treatment received according the following model:
logit(p(Y = 1|Z,x)) = −1.5 + 0.5x1 + 0.5x2 + 0.3x3 + θcZ. (11)
In this model, exp θc is the conditional odds ratio (OR). We used the
method described in [35] to find the value of θc to obtain the desired
relative risk (RR). In order to have a RR of 1 θc = 0, and to have a RR
of 2, θc = 1.221 and 1.289 for ρ = 0.3 and ρ = 0.6, respectively.
With the non-null value of θc, the marginal OR is 2.894 and the risk dif-
ference is 0.236 when ρ = 0.3; they are 2.949 and 0.243 when ρ = 0.6.
With this model, the observed prevalence of the outcome is p0 ≈ 20% in
the control group. For the treated, p1 ≈ 33% under the situation of no
treatment effect (θc = 0), and 58% under a non-null treatment effect sit-
uation (θc 6== 0) when ρ = 0.3, and 35% and 63%, respectively for ρ = 0.6.
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• Missingness mechanism: In this simulation study, we consider a miss-
ing at random (MAR) mechanism. The missingness of each partially ob-
served covariate (X1 and X3) depends on the fully observed covariate X2,
the treatment received Z and the outcome Y and was the same for X1
and X3:
logit(p(R1 = 1|Z, x1, x2, x3, y)) = γ0 + z + x2 + γY y, (12)
logit(p(R3 = 1|Z, x1, x2, x3, y)) = γ0 + z + x2 + γY y, (13)
where R1 and R3 are the missingness indicators for X1 and X3 (equal
to 1 if the value is missing), respectively. We set two values for γY :
γY = (0,−0.4) to have a situation in which the outcome value is not
a predictor of missingness (following Hill [13] or Mitra and Reiter [12])
and a situation in which the missingness depends on the outcome (as in
Bartlett et al. [36] or Seaman and White [31]). When γY = 0, γ0 = −1.5
and when γY = −0.4, γ0 = −1.3 to ensure the same missingness rate of
30% for X1 and X3 across scenarios.
Because we considered two values for the correlation between confounders,
two values for the treatment effect and two values for the association between
missingness and the outcome, a full factorial design leads to 8 scenarios both for
binary and continuous outcomes. We also looked at the impact of the omission of
the outcome in the imputation model in the 8 main scenarios. For one scenario
(RR=2, ρ = 0.6 and the outcome predictor of missingness), we studied the
impact of the number of imputed datasets (M = 5 and M = 20), the sample
size (n = 500) and the missingness rate (10% and 60%) on the results. We also
generated 30 % missing data on the outcome and the treatment indicator on
this scenario assuming MCAR.
For each scenario, 5000 datasets were simulated. Simulations were performed
in R and the mi package was used for multiple imputation [37], based on full
conditional specification (FCS) to generate M = 10 imputed datasets.
6.2 Estimated parameters
For each studied scenario, we estimated the absolute bias of the treatment effect
estimator and its variance estimator, the empirical variance, the coverage rate
and the standardized differences of the confounders after IPTW. In the absence
of weighting, standardized differences are defined as:
SDiff =
100× ∣∣X¯1 − X¯0∣∣√
sˆ21+sˆ
2
0
2
, (14)
for continuous variables, with X¯0, X¯1, sˆ
2
0 and sˆ
2
1 denoting the average value
for covariate and its estimated variance in the control and treatment group,
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respectively. For the binary confounders, the SD is:
SD =
100×
∣∣∣Pˆ1 − Pˆ0∣∣∣√
Pˆ0(1−Pˆ0)+Pˆ1(1−Pˆ1)
2
, (15)
with Pˆ0 and Pˆ1 denoting the estimated proportion of the covariate in the control
and treatment groups.
For PS weighting, standardized differences are calculated by replacing the
unweighted means and variances in (14) and (15) by their weighted equivalents
(weighted by inverse PS). For the MIte approach, standardized differences were
calculated using the PS estimated from each imputed dataset, both to assess
the balance on the originally simulated complete dataset (before imposing miss-
ingness) and on the given imputed dataset. For MIps and MIpar, standardized
differences were calculated using the pooled PS to assess balance on (i) the orig-
inal dataset, (ii) on the average value of the confounders across the imputed
datasets. For (ii) we also calculated the standardized differences separately on
the observed part of the confounders and the average imputed part.
7 Results
Because results were similar for the three measures of interest, we present the
results for relative risks (RR) only in the main text, while results for odds ratios
and risk differences are in the appendices.
7.1 Bias
The absolute bias of the log(RR) of the treatment, for ρ = 0.6, is presented
in Figure 2. Since results for ρ = 0.3 are similar, they are presented in the
Appendices.
Full data, CC and MP analyses: As expected, the IPTW estimator on
the full data (before generating missingness for X1 and X3) is approximately
unbiased and the complete case (CC) estimator is strongly biased in all scenar-
ios except those where the outcome is not associated with missingness and there
is no treatment effect. The MP approach is always biased in the situations con-
sidered, with a bias which can be even stronger than that which is observed for
the CC approach. The reason for this is an incorrect PS model specification in
each pattern of missingness: in the strata in which a confounder is not observed,
the confounder is omitted in the model.
Multiple imputation: First, the results show that the imputation model
must include the outcome, even if the outcome is not a predictor of missingness.
All 3 MI estimators are strongly biased in all scenarios when the outcome is
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not included in the imputation model. Second, when the outcome is included in
the imputation model, the 3 MI approaches lead to a decrease in bias relative
to the crude analysis. However, only the MIte approach leads to an unbiased
estimate in the 8 main scenarios. Combining the PS parameters to estimate the
PS of the average confounders (MIpar) performed better than combining the
PS themselves, but both these approaches are slightly biased.
7.2 Standardized differences between groups
The bias observed for the MP, MIps and MIpar methods can be explained by
a remaining imbalance on the confounders between groups. Standardized dif-
ferences for each covariate are in Table 1. A covariate is usually considered
adequately balanced if its standardized difference is < 10%. IPTW on the full
data achieved a very good balance between groups on the 3 confounders (stan-
dardized difference < 5% for each of the 3 confounders). For the CC approach,
groups were balanced but the bias occurs since excluded individuals are differ-
ent from included individuals on confounding factors. This can be seen as a
selection bias, in which the sample analysed is not representative of the target
population. The PS obtained from the MP approaches balanced the observed
part of the confounders, but not the unobserved part. This means that within
each pattern of missingness, treated and untreated individuals are balanced for
the confounders included in the PS model, but unbalanced on the missing co-
variate because this covariate is an unmeasured confounder in the PS model.
Thus, when the missingness rate increases, imbalances (and consequently, bias
of the treatment effect estimate) increase (see section 7.5). Whereas the PS
estimated from each imputed dataset (MIte) balanced both the observed and
imputed part of the confounders on the given imputed dataset, the average PS
(MIps), the PS of the average confounders (MIpar) and the PS estimated with
MP recovered the balance only the observed part of the confounders, as for the
MP approach. Moreover, in the MIte approach, the balance achieved on the
fully observed covariate (X2) is similar to the balance observed on full data,
whereas the imbalance on this variable with MIps and MIpar is slightly higher.
Finally, the PS estimated in each imputed dataset (MIte) balances observed and
imputed confounders in the given imputed dataset, but this PS did not balance
confounders in the original dataset.
7.3 Coverage rate and standard errors
Figure 3 displays the coverage rate for each method when the outcome is in-
cluded in the imputation model. Each boxplot represents the coverage distribu-
tion for the 8 main scenarios. Because the CC and MP approaches are strongly
biased, their coverage rates are not relevant. The coverage rate for the MIte
approach is close to the nominal value of 95%, confirming that Rubin’s rules
perform well in this context provided that the within-imputation variance takes
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into account the uncertainty in PS estimation.
Table 3 shows the mean estimates from different variance estimators for
each method when the outcome is included in the imputation model. It is
important to note that using a variance estimator for IPTW without taking
into account the PS estimation leads to an overestimated variance. For the
analysis on full data and for MIte, the corrected variances are close to the em-
pirical variance, whereas a naive estimator tends to overestimate the variance
for these approaches. A variance formula accounting for the PS estimation has
not yet been provided for the MP approach. For MIps and MIpar, the uncor-
rected variance estimator whose results are displayed in the table incorporates
the variability linked to PS estimation but not the imputation procedure. The
proposed variance estimator (Appendix 1) performs well in our simulations. In
the scenarios presented in Table 3, the corrected variance is smaller than the
uncorrected variance because the within imputation variance of the PS param-
eters (reflecting the correlation between the confounders and treatment; the
higher this is the larger gain in precision for IPTW) is higher than the between
imputation variance component (noise due to missing data). However, when
the missingness rate increases, the corrected variance can be higher than the
uncorrected, because of a larger heterogeneity between imputed datasets.
7.4 Sample size
Table 17 of the Appendices present the results of one scenario with a non-null
treatment effect with a smaller sample size (n = 500). Results were similar
in terms of bias for n = 500 and n = 2000. Because the variance estimator
for IPTW has been developed for large samples, we observed slightly underes-
timated variances for the full data analysis, MIps and MIparam. This under-
estimation is more pronounced in the CC analysis because the sample for the
analysis is even smaller (269 on average when n = 500).
7.5 Missingness rate
Figure 4 shows the bias when 10% or 60% of each partially observed covariate is
missing. Full results are presented in Appendix 6.3. For a low missingness rate,
the CC and MP approaches are still biased but the 3 MI approaches corrected
the bias. For a missingness rate of about 60% for each covariate, only the
MIte approach showed good performance in terms of bias reduction, confirming
the good statistical properties of this approach even with this large amount of
missing data.
7.6 Number of imputed datasets
In our simulations, increasing the number of imputed datasets did not strongly
impact the results in terms of bias or variance (See Appendix 6.4).
16
8 Application to the motivating example
We applied CC analysis, the MP approach and the three MI strategies to es-
timate the effect of statin treatment on mortality after pneumonia from our
motivating example dataset. For simplicity, we analysed the primary outcome,
mortality within 6 months, as a binary outcome, and estimated the correspond-
ing relative risk and its 95% confidence interval. For each approach, IPTW was
used to account for the confounding. We focused the analysis on the 7158 pa-
tients without coronary heart disease. The propensity score was estimated from
a logistic regression modeling statin use as a function of the following covari-
ates: age, sex, body mass index (BMI), alcohol consumption, smoking status,
diabetes, cardiovascular disease circulatory disease, heart failure, dementia, can-
cer, hyperlipidaemia, hypertension and prescription of antipsychotics, hormone
replacement therapy, antidepressants, steroids, nitrates, beta-blockers, diuret-
ics, anticoagulants and use of antihypertensive drugs. The imbalance between
the study groups is illustrated in Figure 5. Complete case (CC) analysis was
conducted on the 5168 individuals with complete records. For the missingness
pattern approach (MP), 8 patterns were identified. However, some of these
patterns were very rare. For instance, only 6 individuals had only the smoking
status missing, and only 8 had both smoking status and BMI missing. Thus,
we considered only 4 groups:
• complete records (n=5168) for which all the covariates listed above are
included
• individuals with only the alcohol consumption missing (n=455)
• individuals with only BMI missing (n=575)
• individuals with the smoking status missing (alone or in addition to BMI
and alcohol consumption) and individuals with both BMI and alcohol
consumption missing (n=960)
For multiple imputation (MI), 10 imputed datasets were created. The imputa-
tion model included statin use, mortality and all the variables listed above.
The standardized differences estimated before weighting and after weighting
by PS for CC, MP, MIte, MIps and MIpar are presented in Table 4. The MP and
the 3 MI approaches lead to a similar reduction in imbalance between groups
on the observed variables as compared to the crude standardized differences.
Nevertheless, because of the poor overlap of the patients characteristics between
groups (Figure 5), some covariates are still unbalanced even after MI. However,
for binary covariates, large standardized differences can occur even for slight
imbalance when the prevalence is low. Estimated RR are presented in Table 5.
First, all approaches based on IPTW lead to a treatment effect estimate smaller
than the unweighted treatment effect. The 3 MI approaches lead to similar RR
and these were smaller than the RR obtained from CC and MP analyses. The
small differences between the 3 MI approaches in this example can be explained
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by a low rate of missing data and the fact that the 3 partially observed covariates
were not strong confounders.
9 Discussion
This paper aimed to address three main questions about multiple imputation
in the context of IPTW: (i) does the outcome have to be included in the im-
putation model? (ii) should we apply Rubin’s rules on the IPTW treatment
effect estimates or on the PS estimates themselves? (iii) how should we esti-
mate the variance of the IPTW estimator after MI? First, results showed that
the outcome must be included in the imputation model, even if the outcome is
not a predictor of missingness. This is well known in the context multivariable
regression, but can be seen as counter intuitive in the PS paradigm since the
PS model is built without reference to the outcome. The simulation results
showed a bias in the 3 MI estimators when the outcome was omitted from the
imputation model, even when the outcome was not a predictor of missingness.
This may explain the bias observed in Mitra and Reiter’s study [12] for PS
matching. Second, we showed that combining the treatment effects after MI
(MIte approach) is the preferred MI strategy in terms of bias reduction under a
MAR mechanism. This estimator is the only of the 3 MI estimator to be proven
consistent and to provide good balancing properties. Even though MIps and
MIpar are not consistent estimators of the treatment effect, they can reduce the
bias observed for CC analysis, in particular when the rate of missing data is
low. Combining the PS or the PS parameters has no clear advantage for IPTW,
but may be useful in the context of PS matching: because it involves only one
treatment effect estimation, it could provide computational advantage for large
datasets. In addition, MIte for PS matching implies that the M treatment ef-
fect estimates are estimated from different matched sets, potentially of different
sample sizes, leading to a more complex variance estimation because of these
different sample sizes. In our illustrative example, in which the missingness rate
was moderate, the relative risks estimated with the 3 MI estimators were very
similar.
Third, as long as the uncertainty in the PS estimation is taken into account in
the variance estimation [26], Rubin’s rules perform well for MIte, even for mod-
erate sample size (n=500). For MIpar, the proposed variance approximation
(Appendix 1) showed good performance in our simulation study.
The 3 MI approaches differ in terms of their balancing properties. We showed
that whereas the PS estimated in each dataset in the MIte approach can bal-
ance confounders between groups in each imputed dataset, this is no longer
true for MIps and MIpar. However, the best method to assess covariate balance
after MI remains unknown. With MIte, the aim being to estimate a treat-
ment effect from each dataset, we require balance between groups within each
imputed dataset. In contrast, for MIps and MIpar, we need further investi-
gation to know if we should assess the balancing properties of the pooled PS
on the average confounder values across the imputed dataset or on each dataset.
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The MP approach, which is widely used in practice to handle missing data
for PS analysis, revealed poor performance under a MAR mechanism. This can
be explained by the inability of the generalised propensity score to balance the
missing component of the confounders. Moreover, its application on our real
life example was challenging because of the sample size was not large enough
within each missingness pattern to estimate the PS.
This work has some limitations. We generated only 3 confounders in our sim-
ulation, whereas PS are often built from a large number of confounders, despite
the recent recommendation of parsimonious models [38]. Moreover, we studied
only the common situation of log-linear relationships between the confounders
and the outcome and between the confounders and the treatment status. In the
presence of interactions or quadratic terms in these two models, the specification
of the imputation model can be less straightforward, requiring further efforts
to ensure the imputation model is compatible with the substantive (analysis)
model [36].
In conclusion, for IPTW, multiple imputation followed by pooling of treat-
ment effect estimates is the preferred approach amongst those studied when
data are missing at random, and the outcome must be included in the imputa-
tion model.
Funding: This work has been supported by the MRC (project grant MR/M013278/1).
Supplementary material: Complementary results are provided in Appen-
dices
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Table 1: Standardized differences (in %) after IPTW for each method for one
scenario: RR=2, ρ = 0.6, outcome predictor of missingness and included in the
imputation model. n=2000.
Method X1 X2 X3
Crude (without IPTW) 81.3 74.7 51.7
Full 4.6 4.6 2.4
CC (n=1074) 7.6 7.3 3.5
MP
Balance on full data 14.6 4.3 8.5
Balance on the observed part of the covariate 6.1 4.3 2.9
Balance on the missing part of the covariate 48.6 NA 28.3
MIte
Balance on full data 15.0 4.5 9.1
Balance on each imputed dataset 4.5 4.5 2.4
MIps
Balance on full data 15.9 5.5 10.7
Balance on the average imputed dataset 15.8 5.5 10.6
Balance on the observed part of the covariate 7.6 5.5 4.9
Balance on the imputed part of the covariate 58.1 NA 36.9
MIpar
Balance on full data 15.1 4.8 9.6
Balance on the average imputed dataset 14.7 4.8 9.7
Balance on the observed part of the covariate 7.7 4.8 5.4
Balance on the imputed part of the covariate 52.5 NA 34.3
CC: complete case; MP: missingness pattern; MIte: treatment effects combined after
multiple imputation; MIps: propensity scores combined after multiple imputation; MIpar:
propensity score parameters combined after multiple imputation. RR: relative risk. NA: not
applicable because X2 is fully observed.
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Table 5: Estimate of the relative risk of mortality and its 95% confidence interval
for statin vs non statin users (motivating example). n=7158.
Method R̂R 95% CI(R̂R)
Crude 0.587 [0.497;0.684]
CC 0.702 [0.534;0.924]
MP 0.708 [0.555;0.904]
MIte 0.654 [0.513;0.835]
MIps 0.653 [0.512;0.834]
MIpar 0.654 [0.513;0.834]
RR: relative risk. CC: complete case; MP: missingness pattern; MIte:
treatment effects combined after multiple imputation; MIps: propensity scores
combined after multiple imputation; MIpar: propensity score parameters
combined after multiple imputation. RR: relative risk.
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Figure 1: The three approaches considered after multiple imputation (MI) of
the partially observed confounders
? are missing values on the original dataset. ∗(k), (k = 1, ...,M) are imputed values in
the kth imputed dataset. θˆ(k) and eˆ(k) are the estimated treatment effect and estimated
propensity scores, respectively from the kth imputed dataset , (k = 1, ...,M). The MIte
approach consists of pooling the M treatment effects estimated with IPTW on each imputed
dataset. MIps estimate is obtained by using the average PS across the M imputed datasets
in the IPTW estimator. Finally, the MIpar approach uses the PS of the average confounder
value across the M imputed dataset. The PS is estimated using the average PS parameters
as regression coefficients.
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Figure 2: Absolute value of the bias for the 8 main scenarios.
CC: complete case; MP: missingness pattern; MIte: treatment effects combined after multiple
imputation; MIps: propensity scores combined after multiple imputation; MIpar: propensity
score parameters combined after multiple imputation. For the 3 MI approaches ’+’ means
that the outcome is included in the imputation model, ’-’ means that the outcome is not in
the imputation model. RR: relative risk.
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Figure 3: Coverage rate of the 95%CI for each method compared
Results are pooled for the 8 main scenarios. CC: complete case; MP: missingness pattern;
MIte: treatment effects combined after multiple imputation; MIps: propensity scores
combined after multiple imputation; MIpar: propensity score parameters combined after
multiple imputation. RR: relative risk.
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CC: complete case; MP: missingness pattern; MIte: treatment effects combined after
multiple imputation; MIps: propensity scores combined after multiple imputation; MIpar:
propensity score parameters combined after multiple imputation. RR: relative risk.
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Figure 5: Distribution of the propensity score estimated on complete cases for
statin users and non users (n=5168).
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Appendix
Appendix 1: Variance estimate for MIpar
In this section, we provide a crude approximation to the variance for our MIpar
estimator. In MIpar, we take the average propensity score parameters across
imputed datasets, α, and the average of each covariate across imputed dataset
for each individual, Xi = (Xobs,i,
∑
k X
(k)
m,i/K) and use these to calculate the
propensity score, e(Xi;α). The MIpar treatment effect estimate is:
θˆMIpar =
∑
i
YiZi
e(Xi;α)∑
i
Zi
e(Xi;α)
−
∑
i
Yi(1−Zi)
(1−e(Xi;α))∑
i
(1−Zi)
(1−e(Xi;α))
If we let I represent the imputation distribution, and W the distribution of
observed data (Y, Z,Xobs), the variance of the treatment effect estimate is given
by
V [θˆMIpar ] = EW
[
VI|W (θˆMIpar )
]
+ VW
(
EI|W [θˆMIpar ]
)
(16)
Suppose αˆF denotes the propensity score parameters that would have been
obtained in the full data, then
EI|W [ θˆMIpar ] =
∑
i
YiZi
e(Xi;αˆF )∑
i
Zi
e(Xi;αˆF )
−
∑
i
Yi(1−Zi)
(1−e(Xi;αˆF ))∑
i
(1−Zi)
(1−e(Xi;αˆF ))
+ rn
with rn
p→ 0 as n → ∞. This is simply the full-data IPTW estimate, with
the propensity scores evaluated at X (and at the full data parameter estimates)
rather than X. Following Williamson et al., the same calculation shows that
the large-sample variance of this full-data estimate, evaluated at X rather than
X, is given by:
VW
(
EI|W [ θˆMI ]
)
= Vun − vTCαv + 
where Vun is the uncorrected variance estimate, that is considering that the
PS is a true value rather than an estimate, which can be estimated by:
Vˆun =
K21
nwˆ1
2
n∑
i=1
(Yi − µˆ1)2Zi
eˆ2i
+
K20
nwˆ0
2
n∑
i=1
(Yi − µˆ0)2(1− Zi)
(1− eˆi)2 ,
and
vˆ =
K1
nwˆ1
n∑
i=1
x¯i(Yi − µˆ1)Zi(1− eˆi)
eˆi
+
K0
nwˆ0
n∑
i=1
x¯i(Yi − µˆ1)(1− Zi)eˆi
(1− eˆi) .
µˆ1 and µˆ0 are the marginal (weighted) means in the treated and control group,
and wˆ1 and wˆ0 the average estimated weights for IPTW in the treated and
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control group, respectively, and eˆi = e(x¯i; αˆ). Finally, the quantities K0 and
K1 depend on the measure of interest for the treatment effect. For a difference in
mean or a risk difference, K0 = K1 = 1. For a relative risk, K0 = µˆ0
−1 andK1 =
µˆ1
−1, and for an odds ratio, K0 = {µˆ0(1− µˆ0)}−1 and K1 = {µˆ1(1− µˆ1)}−1.
Cα is n
2×the variance/covariance matrix of the estimated PS parameters αˆ
in the full data, which we estimate by the within-imputation matrix W. The
additional part of the variance is  = 2vCα
∗, where
∗ =
1
nE[Z/e(x¯;αF )]
E
[
x>(Y − µF1 )Z
{
(e(x;αF )− e(x;αF )
e(x;αF )
}]
+
1
nE[(1− Z)/(1− e(x¯;αF ))]E
[
x>(Y − µF0 )(1− Z)
{
(1− e(x;αF ))− (1− e(x;αF )))
1− e(x;αF )
}]
This is the only part of the variance which involves the full (unobserved) data.
The magnitude of this term is driven partly by the difference between the
propensity score evaluated at the average covariates across imputed datasets
and the true (possibly unobserved) covariate values. For complete cases, there-
fore, this term is 0. We could attempt to estimate this component using the
imputed datasets. However, we take a pragmatic approach and assume that
pooling of the propensity scores is undertaken due to a desire to avoid the need
to retain all K imputed datasets. Therefore, we ignore this term in the simu-
lation study and evaluate the performance of the estimator without this term.
Thus, we assume that approximately
V̂W
(
EI|W [ θˆMI ]
)
= Vˆun − vˆTWvˆ (17)
This is our estimator for the second term in 16. For the first term, we begin
by noting that, conditional on the observed data (Y,Z,Xobs), we have approxi-
mately,
VI|W (θˆMIpar ) =
(
∂θˆMIpar
∂α
)T
CovI|W (α)
(
∂θˆMIpar
∂α
)
Noting that the average of the propensity score parameters across imputed
datasets is also the standard MI estimate of these parameters,
Ĉov(α) =
(
1 +
1
M
)
B
where B is the between-imputation covariance matrix of the propensity score
parameters. Differentiating the estimate above gives
∂θˆMI
∂α
= −
∑
i
[
(Y−µˆ1)Zxe(x;α)(1−e(x;α))
(e(x;α))2
]
∑
i
[
Z
e(x;α)
] − ∑i
[
(Y−µˆ0)(1−Z)xe(x;α)(1−e(x;α))
(1−e(x;α))2
]
∑
i
[
(1−Z)
(1−e(x;α))
] = −vˆ
Thus, we can estimate
Ê
[
VI|W (θˆMI)
]
=
(
1 +
1
M
)
vˆTBvˆ (18)
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Putting (17) and (18) into (16), we have
Vˆ (θˆMI) = Vˆun − vˆT
{
W −
(
1 +
1
M
)
B
}
vˆ
Note that the two components of variability in the propensity score parameters
- W and B - act in opposite directions on the variance of the treatment effect
estimator. The between-imputation variance reflects noise due to the missing
data, thus this adds to the overall variance of the treatment effect estimator.
The within-imputation variance reflects the correlation between the confounders
and treatment (ie covariate imbalance), which results in smaller variance of
the treatment effect estimator (since the IPTW estimator gains precision by
rebalancing imbalanced covariates).
35
Appendix 2: Assumptions required when pooling
treatment effects
Notations Let X the vector of confounders be split into observed and partially
missing, X = (Xobs,Xmiss). X
(k)
m is the imputed value for Xmiss in the k
th im-
puted dataset (k = 1, ..,M) and α(k) the true propensity score parameters in the
kth imputed dataset (with α(k) = α, the overall true PS parameters, k=1,...,M).
Appendix 2a: Proof that E[Z|Xobs,X(k)m ] = e(Xobs,X(k)m ;α(k))
We have:
E[Z|Xobs,X(k)m ] =
Pr(X
(k)
m |Z = 1,Xobs)Pr(Z = 1|Xobs)∑
z=0,1 Pr(X
(k)
m |Z = z,Xobs)Pr(Z = z|Xobs)
. (19)
We now express the probabilities Pr(X
(k)
m |Z = z,Xobs) in terms of the (unob-
served) missing values:
Pr(X(k)m |Z = z,Xobs) =
∑
y=0,1
Pr(X(k)m |Z = z,Xobs, Y = y)Pr(Y = y |Z = z,Xobs)
=
∑
y=0,1
Pr(Xmiss|Z = z,Xobs, Y = y)Pr(Y = y |Z = z,Xobs)
= Pr(Xmiss|Z = z,Xobs),
if the values are imputed from the true distribution. Substituting this back into
(19) gives
E[Z|Xobs,X(k)m = x] = E[Z|Xobs,Xmiss = x] = e(Xobs,x;α) = e(Xobs,X(k)m = x;α(k)).
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Appendix 2b: Proof that Y z=1 ⊥ Z |Xobs,X(k)m
We have:
Pr(Z = 1|Y z=1 = y1,Xobs,X(k)m )
=
Pr(X
(k)
m |Z = 1, Y z=1 = y1,Xobs)Pr(Z = 1|Y z=1 = y1,Xobs)
Pr(X
(k)
m |Y z=1 = y1,Xobs)
=
Pr(Xmiss|Z = 1, Y z=1 = y1,Xobs)Pr(Z = 1|Y z=1 = y1,Xobs)
Pr(Xmiss|Y1 = y1,Xobs) (20)
= Pr(Z = 1|Y z=1 = y1,Xobs,Xmiss)
= Pr(Z = 1|Xobs,Xmiss) (21)
= Pr(Z = 1|Xobs,X(k)m ), (22)
where (20) was reached by noting that Y1 = Y when Z = 1, (21) is true by
the SITA assumption for the full data (Assumption 1), and (22) was shown in
Appendix 1a.
Proof that Y z=0 ⊥ Z |Xobs,X(k)m follows in a similar way.
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Appendix 3: inconsistency of MIps and MIpar
estimators: a counter example
Neither θˆMIps nor θˆMIpar are consistent estimators. This can be shown by a
simple counter-example. Suppose we have a single confounder, X, which is
MAR depending on treatment Z only:
X ∼ Bernouilli(0.5)
Z ∼
{
Bernouilli(0.1) if X = 0
Bernouilli(0.9) if X = 1
Y ∼
{
Bernouilli(0.1) if X = 0 and/or Z = 0
Bernouilli(0.9) if X = Z = 1
R ∼
{
1 if Z = 0
Bernouilli(0.1) if Z = 1
Xobs = X : R = 1 and Xmiss = X : R = 0. The treatment model corresponds
to: ln(e/(1−e)) = −2.1972246+4.3944492X, thusα = (−2.1972246, 4.3944492)T .
The true expected potential outcome is E[Y z=1] = 0.5.
Consistency when pooling propensity scores When Z = 1 and Y = 1,
the expected propensity score is E[e(Xobs, X(k)m ;α)] = E [E[e(X,α)|X]] = 0.89.
When Z = 1, Y = 1, X can take values of 0, 1 or missing, producing average
(expected) propensity scores of 0.1, 0.9, and 0.89, respectively. Thus
E
[
Y Z
E[e(Xobs, X(k)m ;αt)]
]
= Pr(X = 0, Z = 1, Y = 1, R = 1)/0.1
+ Pr(X = 1, Z = 1, Y = 1, R = 1)/0.9 + Pr(Z = 1, Y = 1, R = 0)/0.89
= 0.465
So E[ Y Z
E
[
e(Xobs,X
(k)
m ;α)
] ] 6= E[Y z=1]. Thus pooling the propensity scores will pro-
duce an inconsistent estimator here.
Consistency when pooling propensity score parameters When Y =
1, Z = 1, the expected value of X is µbarXE[Xmiss|Z = 1, Y = 1] = Pr(X =
1, Z = 1, Y = 1)/Pr(Z = 1, Y = 1) = 81/82. The true propensity score
evaluated at α with X = 0, 1 and 81/82 is 0, 1, and 0.895, respectively. Then,
E
[
Y Z
e(Xobs, µX ;α)
]
= Pr(X = 0, Z = 1, Y = 1, R = 1)/0.1
+ Pr(X = 1, Z = 1, Y = 1, R = 1)/0.9 + Pr(Z = 1, Y = 1, R = 0)/0.895
= 0.462
So E
[
Y Z
e(Xobs,µX ;α)
]
6= E[Y z=1]. Thus pooling the propensity scores will produce
an inconsistent estimator here also.
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Appendix 4: Consistency for the MP approach
Let e∗ be the generalized PS estimated from the MP approach. Rosenbaum
and Rubin showed that Xobs ⊥ Z|e∗. This implies that for each value of e∗, the
observed part of the confounders and the frequency of missingness are balanced
between groups. However, they state that we do not have: X ⊥ Z|e∗. Because
we do not have this conditional independence, e∗ is not a balancing score for
(Xobs,Xmiss) and thus the MP estimator of treatment effect is inconsistent,
without making further conditional independence assumptions.
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Appendix 5: PS distribution in the simulation
study
Figure 6: Distribution of the propensity score in both groups in our simulation
study.
These distributions are obtained from one dataset of size n=1000000.
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Appendix 6: Additional simulation results
6.1: Full results for a binary outcome
Table 6: Scenario 1: RR=1, ρ = 0.3 and outcome predictor of missingness and
included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.538 0.000 0.092 0.182 0.003 0.036 0.021
Variance 0.006 0.009 0.025 0.011 0.010 0.008 0.009
Empirical variance 0.006 0.009 0.026 0.009 0.009 0.009 0.009
Coverage rate 0.000 0.947 0.898 0.570 0.959 0.929 0.944
OR
Bias 0.722 0.000 0.121 0.239 0.004 0.048 0.028
Variance 0.012 0.015 0.041 0.019 0.016 0.015 0.015
Empirical variance 0.012 0.015 0.042 0.016 0.015 0.015 0.015
Coverage rate 0.000 0.948 0.908 0.580 0.958 0.931 0.946
Risk difference
Bias 0.136 0.000 0.022 0.043 0.001 0.009 0.005
Variance 0.000 0.000 0.001 0.001 0.001 0.000 0.000
Empirical variance 0.000 0.000 0.001 0.001 0.000 0.000 0.000
Coverage rate 0.000 0.949 0.928 0.602 0.960 0.935 0.947
* For complete case analysis, the average sample size is 1061.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
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Table 7: Scenario 2: RR=1, ρ = 0.3 and outcome independent of missingness
but included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.539 -0.001 -0.007 0.082 0.002 0.030 0.016
Variance 0.006 0.009 0.030 0.011 0.010 0.008 0.009
Empirical variance 0.006 0.009 0.031 0.009 0.009 0.009 0.009
Coverage rate 0.000 0.949 0.941 0.890 0.958 0.938 0.943
OR
Bias 0.722 0.000 -0.006 0.107 0.003 0.040 0.022
Variance 0.012 0.015 0.044 0.018 0.016 0.015 0.015
Empirical variance 0.012 0.015 0.046 0.016 0.015 0.015 0.015
Coverage rate 0.000 0.949 0.943 0.895 0.958 0.939 0.945
Risk difference
Bias 0.136 0.000 0.001 0.019 0.001 0.007 0.004
Variance 0.000 0.000 0.001 0.001 0.001 0.000 0.000
Empirical variance 0.000 0.000 0.001 0.001 0.000 0.000 0.000
Coverage rate 0.000 0.948 0.942 0.903 0.959 0.942 0.946
* For complete case analysis, the average sample size is 1103.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
Table 8: Scenario 3: RR=2, ρ = 0.3 and outcome predictor of missingness and
included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.438 0.000 0.111 0.145 0.002 0.028 0.016
Variance 0.004 0.006 0.013 0.007 0.006 0.006 0.006
Empirical variance 0.004 0.006 0.014 0.006 0.006 0.006 0.006
Coverage rate 0.000 0.949 0.815 0.584 0.958 0.931 0.940
OR
Bias 0.747 0.002 0.130 0.227 0.004 0.047 0.026
Variance 0.011 0.014 0.036 0.018 0.016 0.014 0.015
Empirical variance 0.011 0.015 0.038 0.016 0.015 0.015 0.015
Coverage rate 0.000 0.947 0.887 0.622 0.958 0.930 0.942
Risk difference
Bias 0.163 0.000 0.018 0.048 0.001 0.010 0.005
Variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Coverage rate 0.000 0.948 0.928 0.661 0.957 0.928 0.939
* For complete case analysis, the average sample size is 1076.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
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Table 9: Scenario 4: RR=2, ρ = 0.3 and outcome independent of missingness
but included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.439 0.002 0.102 0.074 0.003 0.027 0.016
Variance 0.004 0.006 0.015 0.007 0.006 0.006 0.006
Empirical variance 0.004 0.006 0.016 0.006 0.006 0.006 0.006
Coverage rate 0.000 0.950 0.850 0.868 0.958 0.931 0.941
OR
Bias 0.748 0.005 0.051 0.112 0.007 0.041 0.023
Variance 0.011 0.014 0.036 0.018 0.016 0.014 0.015
Empirical variance 0.011 0.015 0.038 0.016 0.015 0.015 0.015
Coverage rate 0.000 0.950 0.935 0.883 0.959 0.933 0.941
Risk difference
Bias 0.163 0.001 -0.014 0.023 0.001 0.008 0.004
Variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Coverage rate 0.000 0.951 0.919 0.898 0.959 0.936 0.943
* For complete case analysis, the average sample size is 1103.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
Table 10: Scenario 5: RR=1, ρ = 0.6 and outcome predictor of missingness and
included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.650 0.001 0.099 0.162 0.006 0.036 0.022
Variance 0.006 0.009 0.027 0.012 0.009 0.009 0.009
Empirical variance 0.006 0.009 0.029 0.010 0.009 0.009 0.009
Coverage rate 0.000 0.945 0.886 0.686 0.955 0.928 0.937
OR
Bias 0.883 0.002 0.128 0.214 0.008 0.048 0.029
Variance 0.011 0.015 0.044 0.020 0.017 0.015 0.015
Empirical variance 0.012 0.016 0.047 0.017 0.016 0.016 0.016
Coverage rate 0.000 0.945 0.896 0.693 0.955 0.928 0.938
Risk difference
Bias 0.169 0.001 0.023 0.040 0.002 0.009 0.006
Variance 0.000 0.001 0.001 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.001 0.001 0.001 0.001 0.001 0.001
Coverage rate 0.000 0.945 0.914 0.705 0.956 0.932 0.941
* For complete case analysis, the average sample size is 1058.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
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Table 11: Scenario 6: RR=1, ρ = 0.6 and outcome independent of missingness
but included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.649 -0.001 -0.001 0.063 0.003 0.030 0.016
Variance 0.006 0.009 0.033 0.011 0.009 0.009 0.009
Empirical variance 0.006 0.009 0.035 0.010 0.009 0.009 0.009
Coverage rate 0.000 0.944 0.938 0.927 0.954 0.931 0.940
OR
Bias 0.881 0.000 0.002 0.084 0.005 0.040 0.022
Variance 0.011 0.015 0.048 0.020 0.017 0.015 0.015
Empirical variance 0.011 0.016 0.051 0.017 0.016 0.015 0.016
Coverage rate 0.000 0.944 0.941 0.929 0.954 0.933 0.941
Risk difference
Bias 0.169 0.000 0.002 0.016 0.001 0.007 0.004
Variance 0.000 0.001 0.001 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.001 0.001 0.001 0.001 0.001 0.001
Coverage rate 0.000 0.945 0.938 0.934 0.953 0.936 0.941
* For complete case analysis, the average sample size is 1099.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
Table 12: Scenario 7: RR=2, ρ = 0.6 and outcome predictor of missingness and
included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.529 0.002 0.141 0.130 0.005 0.028 0.017
Variance 0.004 0.006 0.014 0.008 0.007 0.006 0.006
Empirical variance 0.004 0.006 0.014 0.007 0.006 0.006 0.006
Coverage rate 0.000 0.947 0.769 0.691 0.957 0.932 0.942
OR
Bias 0.924 0.005 0.148 0.210 0.009 0.047 0.028
Variance 0.011 0.016 0.040 0.022 0.018 0.016 0.016
Empirical variance 0.011 0.017 0.040 0.018 0.017 0.016 0.017
Coverage rate 0.000 0.948 0.887 0.712 0.958 0.932 0.943
Risk difference
Bias 0.199 0.001 0.017 0.045 0.002 0.011 0.006
Variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Coverage rate 0.000 0.945 0.937 0.731 0.957 0.932 0.942
* For complete case analysis, the average sample size is 1074.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
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Table 13: Scenario 8: RR=2, ρ = 0.6 and outcome independent of missingness
but included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.531 0.002 0.138 0.057 0.005 0.027 0.016
Variance 0.004 0.006 0.016 0.008 0.007 0.006 0.006
Empirical variance 0.004 0.006 0.017 0.007 0.006 0.006 0.006
Coverage rate 0.000 0.947 0.793 0.921 0.960 0.937 0.946
OR
Bias 0.927 0.006 0.077 0.091 0.009 0.041 0.024
Variance 0.011 0.016 0.039 0.021 0.018 0.016 0.016
Empirical variance 0.011 0.016 0.041 0.017 0.016 0.016 0.016
Coverage rate 0.000 0.949 0.935 0.924 0.959 0.938 0.944
Risk difference
Bias 0.200 0.002 -0.015 0.020 0.002 0.009 0.005
Variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Coverage rate 0.000 0.947 0.918 0.926 0.955 0.934 0.941
* For complete case analysis, the average sample size is 1099.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
Table 14: Scenario 9: RR=1, ρ = 0.3 and outcome predictor of missingness but
not included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.540 0.000 0.093 0.182 0.084 0.100 0.090
Variance 0.006 0.009 0.025 0.011 0.010 0.009 0.009
Empirical variance 0.006 0.009 0.026 0.010 0.008 0.008 0.008
Coverage rate 0.000 0.946 0.892 0.573 0.883 0.807 0.835
OR
Bias 0.724 0.001 0.121 0.239 0.111 0.132 0.119
Variance 0.012 0.015 0.041 0.019 0.017 0.015 0.015
Empirical variance 0.012 0.015 0.043 0.017 0.015 0.015 0.015
Coverage rate 0.000 0.947 0.901 0.580 0.886 0.810 0.838
Risk difference
Bias 0.136 0.000 0.022 0.043 0.020 0.024 0.022
Variance 0.000 0.000 0.001 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.000 0.001 0.001 0.000 0.000 0.000
Coverage rate 0.000 0.947 0.920 0.598 0.892 0.820 0.849
* For complete case analysis, the average sample size is 1060.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
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Table 15: Scenario 10: RR=1, ρ = 0.3 and outcome independent of missingness
and not included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.540 0.000 -0.006 0.082 0.088 0.098 0.090
Variance 0.006 0.009 0.030 0.011 0.010 0.008 0.009
Empirical variance 0.006 0.009 0.032 0.009 0.008 0.008 0.008
Coverage rate 0.000 0.947 0.942 0.891 0.882 0.824 0.845
OR
Bias 0.724 0.000 -0.005 0.108 0.116 0.129 0.119
Variance 0.012 0.015 0.045 0.018 0.017 0.015 0.015
Empirical variance 0.012 0.015 0.047 0.016 0.014 0.014 0.014
Coverage rate 0.000 0.947 0.941 0.894 0.884 0.827 0.847
Risk difference
Bias 0.136 0.000 0.001 0.020 0.021 0.024 0.022
Variance 0.000 0.000 0.001 0.001 0.001 0.000 0.000
Empirical variance 0.000 0.000 0.001 0.001 0.000 0.000 0.000
Coverage rate 0.000 0.948 0.940 0.903 0.893 0.835 0.855
* For complete case analysis, the average sample size is 1103.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
Table 16: Scenario 11: RR=2, ρ = 0.3 and outcome predictor of missingness
but not included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.436 0.000 0.111 0.144 0.065 0.077 0.070
Variance 0.004 0.006 0.013 0.007 0.006 0.006 0.006
Empirical variance 0.004 0.006 0.014 0.006 0.006 0.006 0.006
Coverage rate 0.000 0.946 0.818 0.583 0.893 0.825 0.854
OR
Bias 0.743 0.001 0.130 0.227 0.108 0.128 0.115
Variance 0.011 0.014 0.036 0.018 0.017 0.015 0.015
Empirical variance 0.011 0.015 0.038 0.017 0.015 0.015 0.015
Coverage rate 0.000 0.945 0.894 0.614 0.887 0.819 0.847
Risk difference
Bias 0.162 0.000 0.018 0.048 0.024 0.028 0.025
Variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Coverage rate 0.000 0.944 0.923 0.646 0.886 0.822 0.851
* For complete case analysis, the average sample size is 1075.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
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Table 17: Scenario 12: RR=2, ρ = 0.3 and outcome independent of missingness
and not included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.437 0.002 0.099 0.073 0.069 0.079 0.073
Variance 0.004 0.006 0.015 0.007 0.006 0.006 0.006
Empirical variance 0.004 0.006 0.016 0.006 0.006 0.006 0.006
Coverage rate 0.000 0.947 0.860 0.875 0.879 0.824 0.843
OR
Bias 0.745 0.004 0.047 0.110 0.115 0.126 0.117
Variance 0.011 0.014 0.036 0.018 0.017 0.015 0.015
Empirical variance 0.011 0.015 0.038 0.016 0.014 0.014 0.015
Coverage rate 0.000 0.947 0.936 0.887 0.877 0.829 0.846
Risk difference
Bias 0.162 0.001 -0.015 0.023 0.026 0.027 0.025
Variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Coverage rate 0.000 0.946 0.913 0.901 0.879 0.836 0.855
* For complete case analysis, the average sample size is 1103.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
Table 18: Scenario 13: RR=1, ρ = 0.6 and outcome predictor of missingness
but not included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.650 0.001 0.096 0.161 0.061 0.082 0.070
Variance 0.006 0.009 0.027 0.012 0.010 0.009 0.009
Empirical variance 0.006 0.009 0.029 0.010 0.009 0.009 0.009
Coverage rate 0.000 0.939 0.896 0.683 0.919 0.858 0.882
OR
Bias 0.883 0.002 0.124 0.214 0.081 0.109 0.094
Variance 0.011 0.015 0.044 0.020 0.017 0.015 0.015
Empirical variance 0.012 0.016 0.046 0.017 0.015 0.015 0.015
Coverage rate 0.000 0.938 0.905 0.690 0.921 0.861 0.885
Risk difference
Bias 0.169 0.001 0.022 0.040 0.015 0.020 0.017
Variance 0.000 0.001 0.001 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.001 0.001 0.001 0.001 0.001 0.001
Coverage rate 0.000 0.939 0.925 0.703 0.925 0.867 0.890
* For complete case analysis, the average sample size is 1058.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
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Table 19: Scenario 14: RR=1, ρ = 0.6 and outcome independent of missingness
and not included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.650 -0.001 -0.001 0.063 0.063 0.080 0.070
Variance 0.006 0.009 0.033 0.011 0.010 0.009 0.009
Empirical variance 0.006 0.009 0.034 0.009 0.008 0.008 0.008
Coverage rate 0.000 0.952 0.937 0.931 0.928 0.870 0.893
OR
Bias 0.882 0.000 0.002 0.083 0.084 0.106 0.093
Variance 0.011 0.015 0.048 0.020 0.017 0.015 0.015
Empirical variance 0.012 0.015 0.051 0.016 0.014 0.014 0.014
Coverage rate 0.000 0.953 0.939 0.935 0.929 0.873 0.896
Risk difference
Bias 0.169 0.000 0.002 0.015 0.016 0.020 0.017
Variance 0.000 0.001 0.001 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.001 0.001 0.001 0.001 0.000 0.000
Coverage rate 0.000 0.953 0.938 0.938 0.932 0.882 0.904
* For complete case analysis, the average sample size is 1099.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
Table 20: Scenario 15: RR=2, ρ = 0.6 and outcome predictor of missingness
but not included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.529 0.000 0.139 0.129 0.048 0.064 0.056
Variance 0.004 0.006 0.014 0.008 0.007 0.006 0.006
Empirical variance 0.004 0.006 0.014 0.006 0.006 0.006 0.006
Coverage rate 0.000 0.953 0.763 0.696 0.929 0.878 0.901
OR
Bias 0.924 0.001 0.144 0.207 0.081 0.107 0.092
Variance 0.011 0.016 0.039 0.021 0.018 0.017 0.017
Empirical variance 0.011 0.016 0.041 0.018 0.016 0.016 0.016
Coverage rate 0.000 0.953 0.897 0.716 0.927 0.872 0.894
Risk difference
Bias 0.199 0.001 0.016 0.045 0.018 0.024 0.021
Variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Coverage rate 0.000 0.948 0.936 0.737 0.925 0.869 0.894
* For complete case analysis, the average sample size is 1074.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
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Table 21: Scenario 16: RR=2, ρ = 0.6 and outcome independent of missingness
and not included in the imputation model.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.530 0.001 0.139 0.057 0.051 0.065 0.058
Variance 0.004 0.006 0.016 0.008 0.007 0.006 0.006
Empirical variance 0.004 0.006 0.018 0.007 0.006 0.006 0.006
Coverage rate 0.000 0.944 0.795 0.918 0.923 0.869 0.891
OR
Bias 0.926 0.003 0.077 0.090 0.086 0.105 0.093
Variance 0.011 0.016 0.039 0.021 0.018 0.016 0.017
Empirical variance 0.011 0.017 0.042 0.018 0.016 0.017 0.017
Coverage rate 0.000 0.945 0.928 0.925 0.921 0.875 0.894
Risk difference
Bias 0.199 0.001 -0.015 0.019 0.019 0.023 0.020
Variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.001 0.002 0.001 0.001 0.001 0.001
Coverage rate 0.000 0.945 0.912 0.927 0.919 0.877 0.894
* For complete case analysis, the average sample size is 1099.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
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6.2: Impact of the sample size
Table 22: Results for one scenario (RR=2, ρ = 0.6 and outcome predictor of
missingness and included in the imputation model) with n = 500.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.442 0.007 0.110 0.153 0.010 0.038 0.024
Variance 0.017 0.022 0.050 0.029 0.026 0.022 0.023
Empirical variance 0.018 0.024 0.059 0.027 0.025 0.024 0.025
Coverage rate 0.065 0.940 0.887 0.855 0.955 0.939 0.943
OR
Bias 0.753 0.015 0.145 0.244 0.020 0.066 0.041
Variance 0.044 0.057 0.139 0.077 0.065 0.058 0.058
Empirical variance 0.045 0.061 0.168 0.071 0.063 0.062 0.063
Coverage rate 0.047 0.942 0.913 0.865 0.952 0.934 0.937
Risk difference
Bias 0.162 0.002 0.021 0.051 0.003 0.013 0.008
Variance 0.002 0.003 0.007 0.004 0.003 0.003 0.003
Empirical variance 0.002 0.003 0.009 0.004 0.003 0.003 0.003
Coverage rate 0.046 0.934 0.902 0.869 0.947 0.928 0.929
* For complete case analysis, the average sample size is 269.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
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6.3: Impact of the missingness rate
Table 23: Results for one scenario (RR=2, ρ = 0.6 and outcome predictor of
missingness and included in the imputation model) with 10% of data missing
for X1 and X3.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.529 0.000 0.066 0.061 0.001 0.009 0.005
Variance 0.004 0.006 0.007 0.008 0.006 0.006 0.006
Empirical variance 0.004 0.006 0.008 0.007 0.006 0.006 0.006
Coverage rate 0.000 0.946 0.874 0.907 0.951 0.945 0.947
OR
Bias 0.924 0.002 0.073 0.098 0.003 0.015 0.009
Variance 0.011 0.016 0.020 0.021 0.017 0.016 0.016
Empirical variance 0.012 0.017 0.021 0.018 0.017 0.017 0.017
Coverage rate 0.000 0.944 0.913 0.904 0.949 0.945 0.946
Risk difference
Bias 0.199 0.001 0.010 0.021 0.001 0.004 0.002
Variance 0.000 0.001 0.001 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.001 0.001 0.001 0.001 0.001 0.001
Coverage rate 0.000 0.942 0.933 0.905 0.948 0.943 0.944
* For complete case analysis, the average sample size is 1609.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
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Table 24: Results for one scenario (RR=2, ρ = 0.6 and outcome predictor of
missingness and included in the imputation model) with 60% of data missing
for X1 and X3.
Crude Full CC* MP MIte MIps MIpar
RR
Bias 0.530 0.001 0.184 0.175 0.010 0.063 0.037
Variance 0.004 0.006 0.074 0.008 0.008 0.006 0.006
Empirical variance 0.004 0.006 0.101 0.007 0.007 0.006 0.007
Coverage rate 0.000 0.945 0.802 0.490 0.962 0.869 0.916
OR
Bias 0.925 0.004 0.184 0.285 0.018 0.105 0.060
Variance 0.011 0.016 0.208 0.025 0.021 0.016 0.017
Empirical variance 0.012 0.017 0.285 0.022 0.019 0.017 0.018
Coverage rate 0.000 0.944 0.889 0.544 0.963 0.863 0.916
Risk difference
Bias 0.199 0.001 0.010 0.062 0.004 0.023 0.013
Variance 0.000 0.001 0.011 0.001 0.001 0.001 0.001
Empirical variance 0.000 0.001 0.014 0.001 0.001 0.001 0.001
Coverage rate 0.000 0.945 0.867 0.578 0.963 0.862 0.913
* For complete case analysis, the average sample size is 399.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
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6.5: Number of imputed datasets
Table 25: Bias of the log(RR), its variance and coverage rate for the 3 MI ap-
proaches according the number M of imputed datasets for one scenario (RR=2,
ρ = 0.6, outcome predictor of missingness and included in the imputation
model).
MIte MIps MIpar
M=5 M=10 M=20 M=5 M=10 M=20 M=5 M=10 M=20
Bias 0.002 0.005 0.003 0.026 0.028 0.031 0.015 0.017 0.018
Variance 0.006 0.007 0.006 0.006 0.006 0.006 0.006 0.006 0.006
Empirical variance 0.006 0.006 0.006 0.006 0.006 0.006 0.006 0.006 0.006
Coverage rate 0.957 0.957 0.953 0.931 0.932 0.924 0.940 0.942 0.937
MIte: treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
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6.5: Partially observed outcome and treatment indicator
Table 26: Results for one scenario (RR=2, ρ = 0.6 and outcome predictor of
missingness and included in the imputation model) with 30% of data missing
for X1, X3, the outcome Y and the treatment indicator Z.
Crude Full CC* MIte
RR
Bias 0.530 0.002 0.207 0.000
Variance 0.004 0.006 0.032 0.014
Empirical variance 0.004 0.006 0.034 0.012
Coverage rate 0.000 0.949 0.770 0.956
OR
Bias 0.926 0.005 0.164 -0.002
Variance 0.011 0.016 0.078 0.034
Empirical variance 0.011 0.016 0.083 0.031
Coverage rate 0.000 0.947 0.906 0.952
Risk difference
Bias 0.200 0.001 -0.002 -0.001
Variance 0.000 0.001 0.004 0.002
Empirical variance 0.000 0.001 0.004 0.002
Coverage rate 0.000 0.950 0.923 0.953
* For complete case analysis, the average sample size is 635.
RR: relative risk; OR: odds ratio; CC: complete case; MP: missingness pattern;
MIte:treatment effects pooled after multiple imputation; MIps: propensity scores pooled
after multiple imputation; MIpar: propensity score parameters pooled after multiple
imputation.
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